Objective: Limited data exist regarding the outcomes after resection of pure hematogenous chest wall (CW) metastases. Therefore, we reviewed our 17 years' experience to determine clinically relevant factors. Methods: A retrospective review of all patients who underwent CW metastasectomy (other than breast cancer) from October 1991 to August 2008 at a single institution was performed. Post-CW metastasectomy survival curves were estimated by the Kaplan-Meier method and compared using log-rank test. Factors predictive of improved survival were determined by univariable and multivariable Cox proportional hazard regression analysis. Results: A total of 90 CW metastasectomies were performed on 79 patients (33 females and 46 males). The median follow-up period was 25.6 months. Operative mortality was 1.1%. The 5-year survival was 40%. Significant factors after multivariable analysis were margin status, histology, and a history of heavy smoking (20 pack years). Microscopically positive margin (P = 0.01; hazard ratio (HR) 2.85; 95% confidence interval (CI) 1.28-6.35) and grossly positive margin (P < 0.01; HR 9.55; 95% CI 2.60-35.1) fared worse. Compared with carcinoma, sarcoma (P < 0.01; HR 3.9; 95% CI 1.7-9.2) and melanoma (P < 0.01; HR 6.4; 95% CI 1.7-24) had worse survival. A history of heavy smoking diminished survival (P < 0.01; HR 3.7; 95% CI 1.6-8.4). Conclusions: The resection of CW metastases in highly selected patients as a part of multimodality treatment has low risk and is associated with prolonged survival. The margin status and histology are significant factors in the survival after CW metastasectomy. In addition, heavy smoking history also has a significant negative impact on survival. #
Introduction
The surgical treatment of multiple hematogenous metastatic tumors of the lungs by pulmonary resection is an established therapeutic measure [1] [2] [3] . Except for sparse articles on the results of resection of hematogenous chest wall (CW) metastasis, there have been limited data regarding the results of resection of solitary hematogenous metastatic disease to the CW. Most series are small and usually extend over several decades, with a variety of approaches to these lesions [4] [5] [6] [7] [8] [9] [10] . Many of these studies have included breast cancer or primary CW tumor. Both are clearly different from hematogenous metastases and even in breast cancer the data support resection [11] [12] [13] [14] . However, their inclusion in the aforementioned studies limits their applicability to the treatment of hematogenous metastases to the CW.
Although CW resection in many centers has been considered infrequently, our center has developed an aggressive multidisciplinary approach toward patients presenting with CW metastatic disease in an attempt to improve patients' survival. We reviewed our approach over a 17-year experience with hematogenous metastatic CW tumors to evaluate the long-term results after CW metastasectomy as well as to identify variables that might influence prognosis. Breast cancer and direct extension of a primary lung cancer were excluded, as local recurrence rather than hematogenous metastasis was likely.
Methods
We reviewed the charts of all patients with CW metastasectomy whose primary tumors were not breast cancer or primary lung cancer extending to the CW, at The University of Texas M.D. Anderson Cancer Center (MDACC) from October 1991 to August 2008. For this study, we defined 'chest wall' as any metastasis involving the sternum, ribs, costovertebral junction and soft tissue of the thoracic cage. Isolated metastasis to the vertebral body, scapula and clavicle were excluded from this analysis.
Institutional Review Board (IRB) approval was obtained, and a retrospective chart evaluation examined the following data elements: age, sex, race, co-morbidity, smoking history, histology, location of primary tumor, history of local recurrence of primary tumor, disease-free interval (DFI) between the time of primary tumor resection and the first distant metastasis diagnosis, presenting signs and symptoms of CW metastasis, number of metastasectomies at other sites, and the use of preoperative radiation therapy. Data regarding the surgical techniques, morbidity and mortality, status of pathologic margins, greatest diameter of the CW metastasis, number and location of the resected ribs, number of repeated CW resection, and the reconstructive techniques were also collected. The use of postoperative adjuvant therapies was identified. Follow-up was performed at postoperative clinic visits 1 week and 6 weeks after surgery with complete physical examination and chest roentgenograms. A repeat chest computed tomography (CT) scan was generally performed 3 months after surgery and repeated every 3 months for the first 2 years, followed by every 6 months for the next 5 years. Patient status (alive or dead) and disease status (free of disease or local vs distant tumor recurrence) were recorded. Survival was defined as the time in months from the date of CW metastasectomy until the date the patient was last known to be alive. Any death from any cause was considered a failure (all-cause mortality was evaluated and included in the survival analysis).
Overall survival curves were estimated by the KaplanMeier method and compared by the log-rank test. Multiple clinical variables were evaluated by univariable analysis using Cox proportional hazards model and Kaplan-Meier curves. These factors are shown in Table 1 . The variables found significant on univariate analysis (P-value 0.25 was considered significant) were selected for the multivariable analysis. Margin status, CW recurrence and postoperative radiotherapy strongly correlate with one another and therefore, to avoid multi co-linearity, we included only margin status in the multivariable model. Wald's stepwise selection with P = 0.10 as entry and removal probability was performed to obtain the final model. Statistical significance was defined as P < 0.05. All statistical analyses were performed with Statistical Package for Social Sciences (SPSS) software (SPSS, Inc., Chicago, IL, USA).
Results

Demographics
Seventy-nine patients had been operated at our center with metastatic tumors involving the CW not derived from breast cancer or primary lung cancer from October 1991 to August 2008. The median age was 49.6 years (range of 14-79) with 33 female and 46 male patients. Complete demographics are illustrated in Table 1 . The most common presentation of CW metastasis was identification during routine radiographic follow-up in 52 of 79 patients (65%) and due to pain in 20 of 79 patients (25%). The average DFI of the patients was 37 months (range, 0-41 years). Nineteen patients (four sarcomas and 15 carcinomas) had a CW metastasis as their primary presentation of metastatic disease. Forty-one patients (28 sarcomas, 11 carcinomas, and two melanomas) had either a history of lung metastasis prior to developing a CW metastasis or lung metastasis identified concurrent with their CW metastasis without any earlier extrathoracic metastasis. The remaining 19 patients (nine sarcomas, eight carcinomas, and two melanomas) had prior extrathoracic metastasis, which had been controlled successfully before presentation of their CW metastasis. Many patients underwent additional metastatectomy at other anatomical locations after their CW resection. The average number of metastasectomies performed in any anatomic location, before and after CW resection, was 2.5 operations per patient (range, 1-6).
Primary tumor location and histology
Thirty-six patients (45%) had primary tumors originating in the trunk, and the most common sites were kidney (17) and uterus (6) . In 31 patients (39%), a limb was the primary site of the tumor (26 upper extremities and five lower extremities). The remaining 12 patients had tumors originating in the head and neck (14%) and the testis (1%). The patients presented with a variety of histologies shown in Table 2 .
Operations
Previously established criteria for pulmonary metastatectomy, including control of all extrathoracic disease, adequate cardiopulmonary reserve, and a technically feasible operation removing all recognized disease in the thorax, was present in all of the patients in this series except three for whom the indication was intractable CW pain with extensive intrathoracic involvement. All patients were considered for surgery, as part of a multidisciplinary approach.
The surgical technique consisted of resection of the entire tumor with the aim of achieving pathologically negative margins, assisted by intra-operative histological confirmation. Every attempt was made to achieve a 2-cm margin around the lesion, if possible. Adhesions between the CW and pulmonary parenchyma were handled by performing en-bloc wedge resection to ensure tumor-free parenchymal margins. The reminder of the lung parenchyma was carefully palpated for additional nodules, which were excised with wedge resection, if present.
The average tumor size was 5.5 cm (range, 1-17.5 cm). A total of 191 ribs were resected during the initial CW resections, with a median of 2.4 ribs per patient (range, 0-7 ribs). The most commonly resected ribs were the seventh (24), followed by the fourth and the second ribs (22 times each). Resection of sternum was done in seven cases. In three patients, resection of the CW was limited to soft tissue only. Marlex mesh was the primary prosthetic material used, and was included in the reconstruction of 56 patients. In a small number of these patients, methyl methacrylate was sandwiched between two sheets of marlex mesh to provide extra rigidity. Diaphragm resections were performed in 10 patients (Table 1) . Reconstruction was done without prosthetic reconstruction in all 10 cases. The techniques employed included either direct closure with interrupted suture or reattachment of the edge of the diaphragm defect to the superior extent of the CW resection. Vertebral body resections were performed in nine patients (Table 1 ). There were no en-bloc resections. All resections were partial and used an intra-lesional resection technique. Reconstruction was performed with a variety of external fixation, including anterior plating and/or posterior rods with pedicle screws. Collaboration with neurosurgery was employed for all of these cases.
Synchronous lung resection was performed in 56 patients and included 46 wedge resections (single or multiple), nine lobectomies and one pneumonectomy. Muscle-flap reconstructions by plastic surgery were required in 18 patients (22%) at the first CW resections (nine latissimus dorsi, five pectoralis major, two rectus abdominis, one trapezius, and one serratus anterior).
Intra-operatively, the final surgical margin was positive or less than 1 mm in 16 patients (eight carcinomas, seven sarcomas, and one melanoma). The most common reason was technical limitations, although a clear reason could not always be determined during this retrospective review. Data on local recurrences were available on 73 of the 79 patients. Local CW recurrence occurred in 28 (38%) patients and correlated with the margin status at the first resection: 27% in R0 cases, 83% in R1 cases, and 100% in R2 cases. The average time to CW recurrence was 9.9 months (range, 1-55 months). Repeated CW metastasectomy was done in seven patients and included one patient with a new CW metastasis (in a new location) and six patients with the local recurrences. The repeat resections were considered curative in four patients, as they had a limited local recurrence at the operative margin (felt to be amenable to surgery), and palliative in two other patients secondary to intractable pain from large recurrences that could not undergo complete resection.
Postoperative complication occurred in 13 patients (16%) after their initial CW resection and consisted of six cases of early re-operation (infection, bleeding, or necrotic flap), three cases of wound infection treated without re-operation, three cases of pneumonia, and one case each of chylothorax and pseudo-membranous colitis. There was one hospital death on postoperative day 45 in a patient with postoperative pneumonia and chylothorax.
A history of radiotherapy was present in 23 patients, with six patients receiving preoperative radiotherapy and 18 receiving postoperative therapy ( Table 1 ). The specific dosing and target volumes varied widely based on the location of the tumor, a history of previous radiation therapy in the same region, and the histology of the tumors. A similar pattern was also present regarding the delivery of chemotherapy with even greater variability secondary to a wide variety of agents, dosing, timing, and combination with radiotherapy. Although most of patients received chemotherapy (either prior to or after resection of their primary tumor or metastasis), any attempt to analyze the contribution of chemotherapy to this population's survival would be hindered secondary to this wide variability.
Survival
Forty deaths occurred during a median follow-up of 25.6 months (range 1-105 months). Median survival was 42 months (95% confidence interval (CI): 23-61 months) and overall 5-year survival was 40.3% (Fig. 1) . The univariable analyses recognized that patients with positive margins (gross or microscopic), local recurrence, and diaphragm involvement were significant predictors of survival. In addition, they showed that histology of carcinoma had a better survival rate vs sarcoma and melanoma (5-year survival 58%, 25%, and 0%, respectively). Larger tumors and tumors that presented with symptoms did not carry a worse prognosis in this series. Similarly, the magnitude of the resections (greater number of ribs, extended resections that required involved lung, or adjacent vertebral body) also did not significantly affect long-term survival, except when the diaphragm was involved (Fig. 2) . The full results of the univariable analyses are shown in Table 1 .
Results of the multivariable analyses are shown in Table 3 . The final model identified margin status (Fig. 3) , histologic type of tumor (Fig. 4) , and a history of heavy smoking (Fig. 5) as independent predictors of survival. [
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Fig. 2. Survival based on diaphragm resection (involvement).
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Discussion
Tumors metastatic to the CW, either bony or soft tissue, are more common than primary CW tumors [15, 16] . In spite of this fact, there are a few previous studies in the medical literature that have exclusively considered treatment of patients with hematogenous secondary CW tumors. The present study reported the experience of a single institution with metastatic CW tumors over a 17-year period, and is one of the largest reported series. The overall 5-year survival of this highly selected group was 40%.
The results in the literature have been mixed. Most of the studies include breast cancer and primary lung cancer, both of which may represent local extension into the CW rather than true metastases, and therefore do not reflect the focus of our work. When the pure CW metastases are separated, the results remain mixed. Incarbone et al. [7] and McCormack et al. [17] reported on five and 23 cases, respectively. Incarbone examined sternal resections specifically and reported only a median survival of 12 month. McCormack's population was similar to our own and their 23 patients experienced only a 7% 5-year survival. Two other studies examining CW resection reported better survivals and included 10 and 36 patients, both closely matching our inclusion criteria [9, 18] . Five-year survivals were 40% and 38%, similar to our results. Two remaining studies [6, 19] included 31 and 23 cases of CW metastasectomy. The first study only reported the 5-year survival of a 20-patient subgroup of the total of 31 patients. These 20 patients with non-pulmonary parenchymal metastatic disease limited to the CW (19 patients) and mediastinum (one patient) had a 5-year survival of 64%. The second study only reported patient status without calculating survival statistics.
Our data, similar to other studies [9, 19] , identified completeness of resection as one of the most important factors in the management of these metastatic tumors. Interestingly, the extent of the resection was not a significant factor. These findings have been suggested by other investigators, although their findings were based on a mixed population of patients. Some investigators [9, 10] recommend excision of the entire length of involved ribs, which was not done in our series. We attempted to obtain a 2-cm rib margin during resection. As only half the patients had true rib involvement at final pathology and as this was not a factor in long-term survival, we are not compelled to alter our practice regarding the use of a 2-cm margin only.
Another interesting finding of this study was the impact of the histology on survival. Although this study included highly selected patients, there was a clear difference in survival between sarcoma and carcinoma patients. Numerous significant differences between these two groups existed in addition to histology. These included the isolated CW metastases, initial site of metastasis within the CW, incidence of diaphragm involvement, number of separate operations for metastatic disease, and concurrent or sequential lung metastases. These factors could be related to the biology of the tumor, referral patterns, or surgeon selection. Other investigators have reported similar differences between sarcoma and carcinoma patients. Jaklitsch et al. [20] demonstrated that sarcoma patients, compared with carcinoma patients, frequently required more than three thoracic metastasectomies and the magnitude of benefit of these sequential thoracic metastasectomies decayed with each subsequent attempt. Poncelet et al. [19] showed that the margin status had a significant role (hazard ratio 2.3) on post-thoracic metastasectomy survival and the incidence of their incomplete resection was 2.2 times more common with sarcoma (38%) than carcinoma tumors (17%). Similarly, the overall survival was better for the carcinoma group (the median survival being 38 vs 30 months); however, it was not statistically significant. Although in our study, the positive surgical margin was more common in carcinoma tumors than in sarcoma (24% vs 17%), we did find a significantly worse survival with sarcomatous tumors. Similar to our study, Poncelet et al. [19] and Robert et al. [21] demonstrated that thoracic metastases from melanoma had poor survival whether in the CW or in the lung; however, our limited numbers of these patients did not allow a detailed analysis.
An interesting finding of our study, not reported in the literature regarding resection of CW metastases, was the impact of heavy smoking (20 pack years) on survival. There [ ( ) T D $ F I G ] is a wealth of epidemiologic evidence from the general cancer literature indicating that smoking may modify the progression and prognosis of cancers. Worse survivals have been reported among patients with lung, breast, ovarian, and prostate cancer [22] [23] [24] [25] . The independent role of heavy smoking in our study could also be related to smoking-linked deaths such as respiratory or cardiovascular disease. The cause of death could not be confirmed in many of our patients as autopsies were not routinely performed.
Interesting factors that did not correlate with survival included the presence or absence of other sites of metastases requiring resection. Neither concurrent nor sequential lung metastases nor a history of extrathoracic metastasectomies impacted the survival of these patients. Clearly, surgeon selection must play a role, although it is interesting that the DFI, both as a categorical and continuous variable, was not a factor. Careful selection of patients should allow reproduction of our results. Some findings that approached significance, such as diaphragm involvement, short DFI, and large numbers of ribs resected, occurred in limited numbers and may reflect the selection bias of the surgeons.
Although we do not want to ignore the potential benefit of chemotherapy on the long-term survival of our patients, the restrictions of this retrospective study design plus the large variety of chemotherapy regimes used did not allow an accurate assessment of its impact.
In conclusion, our findings indicate that margin status and histology are significant factors in the survival after CW metastasectomy. In addition, heavy smoking history also has a significant negative impact on survival. Other factors may influence survival but were not found to be significant in this series, most likely secondary to surgeon selection. Although inclusion of these factors in a physician's decision making regarding potential resection of a CW metastasis is inferred by our findings, the retrospective nature of the analysis and the heavy selection bias inherent in the population being analyzed cannot be disregarded. When confronted by a potentially resectable CW metastasis, it is recommended that these factors, along with a multidisciplinary approach, be used prior to offering an operation. Our series demonstrates that, with careful selection and complete resection, prolonged survival can be obtained in a significant fraction of patients.
